(As of June 2024)
Development Pipelines
Product code | Target Indication | Dosage Form | Development region | Current Phase |
---|---|---|---|---|
M5250 | Pruritus with atopic dermatitis (pediatric) | Injection | JP | March, 2024 Approval |
M5250B | Prurigo nodularis | Injection | JP | March, 2024 Approval |
M5250E | Pruritus with atopic dermatitis (infant) |
Injection | JP | PIII |
M6050C | Acne vulgaris | Topical | JP | PIII |
M6100 | Atopic dermatitis | Topical | JP | PIII |
M6050F | Axillary osmidrosis | Topical | JP | PII |
- Product List
- Product Pipeline
- Business Partnerships
- Business Activities